201
Viruses, Pathogens, and Other Contaminants
Beigel, J.H., Tomashek, K.M., Dodd, L.E., Mehta, A.K., Zingman, B.S., Kalil, A.C., et al.
(2020). Remdesivir for the treatment of Covid-19 — fnal report. N. Engl. J. Med.
383, 1813–1826.
Brauer, M. et al. (2017), Global Burden of Disease Study. The World Bank, https://data.
worldbank.org/indicator/EN.ATM.PM25.MC.ZS (Accessed 03/21/2021).
Carey, B., and Glanz, J. (2020). Aboard the Diamond Princess, a case study in aerosol
transmission. N. Y. Times.
CDC. (2020). COVID-19 and your health. https://www.cdc.gov/coronavirus/2019ncov/transmission/variant.html (Accessed 01/16/2021).
Chan, J.F.-W., Yuan, S., Kok, K.-H., To, K.K.-W., Chu, H., Yang, J., et al. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet 395,
514–523.
Dai, W., Zhang, B., Jiang, X.-M., Su, H., Li, J., Zhao, Y., et al. (2020). Structure-based
design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
Science 368, 1331–1335.
Eli Lilly and Company. (2021). A phase 3 randomized, double-blind, placebo-controlled trial to evaluate the effcacy and safety of LY3819253 alone and in combination with LY3832479 in preventing SARS-CoV-2 infection and COVID-19
in skilled nursing and assisted living facility residents and staff; a NIAID and
Lilly collaborative study (clinicaltrials.gov).
Ember, L. (2006). Anthrax sleuthing. https://cen.acs.org/articles/84/i49/AnthraxSleuthing.html.
Kabani, M. (2021). COVID-19 research points to repurposed drugs. CBS News. https://
www.cbsnews.com/news/covid-19-repurposed-drugs-60-minutes-2021-03-07/
(Accessed 03/16/2021).
Katz, L.M. (2021). (A Little) clarity on convalescent plasma for Covid-19. N. Engl. J. Med.
Khan, F., Stewart, I., Fabbri, L., Moss, S., Robinson, K.A., Smyth, A., and Jenkins,
G. (2021). A systematic review and meta-analysis of Anakinra, Sarilumab,
Siltuximab and Tocilizumab for Covid-19. MedRxiv 2020.04.23.20076612.
Kolata, G. (2021). Drug prevents coronavirus infection in nursing homes, maker
claims. N. Y. Times.
Landrigan, P.J., Fuller, R., Acosta, N.J.R., Adeyi, O., Arnold, R., Basu, N., et al. (2018).
The Lancet commission on pollution and health. The Lancet 391, 462–512.
Lednicky, J.A., Lauzardo, M., Fan, Z.H., Jutla, A., Tilly, T.B., Gangwar, M., et al. (2020).
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients. Int. J.
Infect. Dis. 100, 476–482.
Lu, J., Gu, J., Li, K., Xu, C., Su, W., Lai, Z., Zhou, D., Yu, C., Xu, B., and Yang, Z. (2020,
July). COVID-19 outbreak associated with air conditioning in restaurant,
Guangzhou, China. Emerg. Infect. Dis. J. - CDC. 26(7).
Mayo Clinic. (2019). Legionnaires disease. https://www.mayoclinic.org/diseasesconditions/legionnaires-disease/symptoms-causes/syc-20351747#:~:text=
Legionnaires’%20disease%20is%20a%20severe,bacteria%20from%20water%20
or%20soil (Accessed 03/06/2021).
NIH. (2021). NIH COVID-19 treatment guidelines: Ivermectin. https://www.covid19
treatmentguidelines.nih.gov/antiviral-therapy/ivermectin/ (Accessed 03/16/2021).
Park, S.Y., Kim, Y.-M., Yi, S., Lee, S., Na, B.-J., Kim, C.B., Kim, J., Kim, H.S., Kim, Y.B.,
Park, Y., et al. (2020, August). Coronavirus disease outbreak in call center, South
Korea. Emerg. Infect. Dis. J. – CDC, 26(8), 1666–1670.
Viruses, Pathogens, and Other Contaminants
Beigel, J.H., Tomashek, K.M., Dodd, L.E., Mehta, A.K., Zingman, B.S., Kalil, A.C., et al.
(2020). Remdesivir for the treatment of Covid-19 — fnal report. N. Engl. J. Med.
383, 1813–1826.
Brauer, M. et al. (2017), Global Burden of Disease Study. The World Bank, https://data.
worldbank.org/indicator/EN.ATM.PM25.MC.ZS (Accessed 03/21/2021).
Carey, B., and Glanz, J. (2020). Aboard the Diamond Princess, a case study in aerosol
transmission. N. Y. Times.
CDC. (2020). COVID-19 and your health. https://www.cdc.gov/coronavirus/2019ncov/transmission/variant.html (Accessed 01/16/2021).
Chan, J.F.-W., Yuan, S., Kok, K.-H., To, K.K.-W., Chu, H., Yang, J., et al. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet 395,
514–523.
Dai, W., Zhang, B., Jiang, X.-M., Su, H., Li, J., Zhao, Y., et al. (2020). Structure-based
design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
Science 368, 1331–1335.
Eli Lilly and Company. (2021). A phase 3 randomized, double-blind, placebo-controlled trial to evaluate the effcacy and safety of LY3819253 alone and in combination with LY3832479 in preventing SARS-CoV-2 infection and COVID-19
in skilled nursing and assisted living facility residents and staff; a NIAID and
Lilly collaborative study (clinicaltrials.gov).
Ember, L. (2006). Anthrax sleuthing. https://cen.acs.org/articles/84/i49/AnthraxSleuthing.html.
Kabani, M. (2021). COVID-19 research points to repurposed drugs. CBS News. https://
www.cbsnews.com/news/covid-19-repurposed-drugs-60-minutes-2021-03-07/
(Accessed 03/16/2021).
Katz, L.M. (2021). (A Little) clarity on convalescent plasma for Covid-19. N. Engl. J. Med.
Khan, F., Stewart, I., Fabbri, L., Moss, S., Robinson, K.A., Smyth, A., and Jenkins,
G. (2021). A systematic review and meta-analysis of Anakinra, Sarilumab,
Siltuximab and Tocilizumab for Covid-19. MedRxiv 2020.04.23.20076612.
Kolata, G. (2021). Drug prevents coronavirus infection in nursing homes, maker
claims. N. Y. Times.
Landrigan, P.J., Fuller, R., Acosta, N.J.R., Adeyi, O., Arnold, R., Basu, N., et al. (2018).
The Lancet commission on pollution and health. The Lancet 391, 462–512.
Lednicky, J.A., Lauzardo, M., Fan, Z.H., Jutla, A., Tilly, T.B., Gangwar, M., et al. (2020).
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients. Int. J.
Infect. Dis. 100, 476–482.
Lu, J., Gu, J., Li, K., Xu, C., Su, W., Lai, Z., Zhou, D., Yu, C., Xu, B., and Yang, Z. (2020,
July). COVID-19 outbreak associated with air conditioning in restaurant,
Guangzhou, China. Emerg. Infect. Dis. J. - CDC. 26(7).
Mayo Clinic. (2019). Legionnaires disease. https://www.mayoclinic.org/diseasesconditions/legionnaires-disease/symptoms-causes/syc-20351747#:~:text=
Legionnaires’%20disease%20is%20a%20severe,bacteria%20from%20water%20
or%20soil (Accessed 03/06/2021).
NIH. (2021). NIH COVID-19 treatment guidelines: Ivermectin. https://www.covid19
treatmentguidelines.nih.gov/antiviral-therapy/ivermectin/ (Accessed 03/16/2021).
Park, S.Y., Kim, Y.-M., Yi, S., Lee, S., Na, B.-J., Kim, C.B., Kim, J., Kim, H.S., Kim, Y.B.,
Park, Y., et al. (2020, August). Coronavirus disease outbreak in call center, South
Korea. Emerg. Infect. Dis. J. – CDC, 26(8), 1666–1670.